Digital plurilingual pedagogies in foreign language classes: empowering language learners to speak in the target language von Galante, Angelica, Zeaiter, L. F., dela Cruz, J.W.N., Massoud, N., Lee, L., Aronson, J., de Oliveira, D. S. A., Teodoro-Torres, J. A.

Volltext

Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer von Peters, Solange, Camidge, D. Ross, Shaw, Alice T, Gadgeel, Shirish, Ahn, Jin S, Kim, Dong-Wan, Ou, Sai-Hong I, Pérol, Maurice, Dziadziuszko, Rafal, Rosell, Rafael, Zeaiter, Ali, Mitry, Emmanuel, Golding, Sophie, Balas, Bogdana, Noe, Johannes, Morcos, Peter N, Mok, Tony

Volltext

Pooled Systemic Efficacy and Safety Data from the Pivotal Phase II Studies (NP28673 and NP28761) of Alectinib in ALK-positive Non-Small Cell Lung Cancer von Yang, James Chih-Hsin, Ou, Sai-Hong Ignatius, De Petris, Luigi, Gadgeel, Shirish, Gandhi, Leena, Kim, Dong-Wan, Barlesi, Fabrice, Govindan, Ramaswamy, Dingemans, Anne-Marie C., Crino, Lucio, Lena, Herve, Popat, Sanjay, Ahn, Jin Seok, Dansin, Eric, Golding, Sophie, Bordogna, Walter, Balas, Bogdana, Morcos, Peter N., Zeaiter, Ali, Shaw, Alice T.

Volltext

Metabolic Disposition of Lurbinectedin, a Potent Selective Inhibitor of Active Transcription of Protein-Coding Genes, in Nonclinical Species and Patients von Aviles, P, Altares, R, van Andel, L, Lubomirov, R, Fudio, S, Rosing, H, Márquez Del Pino, F M, Tibben, M M, Benedit, G, Nan-Offeringa, L, Luepke Estefan, X E, Francesch, A, Zeaiter, A, Cuevas, C, Schellens, J H M, Beijnen, J H

Volltext

P2.17-06 Efficacy of Platinum after Lurbinectedin + DOX or Topotecan/CAV in Sensitive Relapsed SCLC Patients in the ATLANTIS Trial von Navarro, A., Smit, E., Carcereny, E., Gutierrez, V., Mavroudis, D., Reinmuth, N., Bustin, F., Lopez-Vilariño, J.A., Gómez, J., Kahatt, C., Zeaiter, A., Cousin, S., Ciuleanu, T.E., Lungulescu, D., Robev, B., Paz-Ares, L.

Volltext

Pooled overall survival and safety data from the pivotal phase II studies (NP28673 and NP28761) of alectinib in ALK-positive non-small cell lung cancer (NSCLC) von Ou, Sai-Hong Ignatius, Gandhi, Leena, Gadgeel, Shirish M., Barlesi, Fabrice, Yang, James Chih-Hsin, De Petris, Luigi, Kim, Dong-Wan, Govindan, Ramaswamy, Dingemans, Anne-Marie C., Crino, Lucio, Herve, Lena, Popat, Sanjay, Ahn, Jin Seok, Dansin, Eric, Zeaiter, Ali Hassan, Müller, Barbara, Johannsdottir, Hrefna, Balas, Bogdana, Morcos, Peter N., Shaw, Alice

Volltext

P1.12-03 Antitumor Activity of Single Agent Lurbinectedin in Patients with Relapsed SCLC Occurring ≥30 Days After Last Platinum Dose von Trigo Perez, J.M., Subbiah, V., Besse, B., Moreno, V., López, R., Sala, M.a., Ponce, S., Fernendez, C., Nieto, A., Kahatt, C., Zeaiter, A., Zaman, K., Boni, V., Arrondeau, J., Martinez, M., Delord, J., Awada, A., Kristeleit, R., Longo, F., Sarantopoulos, J., Rubio, M., Anton, A., Wannesson, L., Valdivia, J., Shappiro, G., Villalobos, V., Santoro, A., D'Arcangelo, M., Aparicio, L., Paz-Ares, L.

Volltext

Updated efficacy and safety from the global phase II NP28673 study of alectinib in patients (pts) with previously treated ALK+ non-small-cell lung cancer (NSCLC) von Barlesi, F., Dingemans, A.-M.C., Yang, J.C.-H., Ou, S.-H.I., Ahn, J.S., De Petris, L., Hughes, B., Lena, H., Bordogna, W., Golding, S., Morcos, P.N., Balas, B., Zeaiter, A., Kim, D.-W.

Volltext

Pooled Systemic Efficacy and Safety Data from the Pivotal Phase II Studies (NP28673 and NP28761) of Alectinib in ALK-positive Non-Small Cell Lung Cancer von Yang, JC-H, Ou, S-HI, De Petris, L, Gadgeel, S, Gandhi, L, Kim, D-W, Barlesi, F, Govindan, R, Dingemans, A-MC, Crino, L, Lena, H, Popat, S, Ahn, JS, Dansin, E, Golding, S, Bordogna, W, Balas, B, Morcos, PN, Zeaiter, A, Shaw, AT

Volltext

AVAglio: A phase III trial of bevacizumab added to standard radiotherapy and temozolomide in patients with newly diagnosed glioblastoma von Chinot, O. L., Wick, W., Saran, F., Mason, W. P., Henriksson, R., Nishikawa, R., Zeaiter, A. H., Moore, N., Das, A., Cloughesy, T. F.

Volltext

Photoluminescence Study of Cu(GaxIn1-x)3Se5 and CuIn3(SxSe1-x)5 Crystals with 0≤x≤1 von Djellal, L., Llinares, C., Yanuar, Yanuar, Guastavino, F., Zeaiter, K., Bayaa, D., Abdelali, M.

Volltext